INVESTMENT AGREEMENTInvestment Agreement • August 16th, 2024 • Personalis, Inc. • Services-medical laboratories • Delaware
THIS INVESTMENT AGREEMENT (this “Agreement”), dated as of August 16, 2024, by and between Personalis, Inc., a Delaware corporation (the “Company”), and Tempus AI, Inc., a Delaware corporation (the “Investor”). Capitalized terms used herein but not otherwise defined shall have the meanings given to them in Section 1.5.
Amendment No. 1 to the Commercialization and Reference Laboratory AgreementReference Laboratory Agreement • August 16th, 2024 • Personalis, Inc. • Services-medical laboratories
This Amendment No. 1 (“Amendment”) is made as of the date of the last signature below (“Amendment Date”) between Personalis, Inc. (“Personalis”) and Tempus AI, Inc. f/k/a Tempus Labs, Inc. (“Tempus”), and amends the Commercialization and Reference Laboratory Agreement with the effective date of November 25, 2023 (the “Agreement”). Tempus and Personalis are each a “Party” and together the “Parties.” The Parties wish to modify the terms of the Agreement as set forth herein. In consideration of the mutual promises herein, the Parties agree as follows:
